...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Message: Insider Selling

Good find ! So netting it out did he increase his upside with more potential shares ? Or did he put net cash in his pocket with less upside potential ?

 

Share
New Message
Please login to post a reply